Mylan's antiretroviral drug Avonza for first-line treatment of HIV/AIDS gained approval for release in India. Mylan says Avonza, recommended by the World Health Organization as an alternative first-line HIV/AIDS treatment, will cost less than other such ARVs.
Sign up for BIO SmartBrief
Biotechnology industry news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.